2–4 Sep 2018
Europe/Berlin timezone

IFN-λ enhances influenza immunity by stimulating TSLP release during intranasal immunization

Not scheduled
15m
Oral presentation

Speaker

A user

Description

Interferon-λ (IFN-λ) acts on epithelial cells and mediates innate antiviral protection of mucosal surfaces. Here we report that IFN-λ can also enhance adaptive immunity following infection of the respiratory tract. Mice deficient in IFN-λ signaling showed an impaired antibody response after influenza virus infection. We further found that subunit vaccines enriched with IFN-λ induced strongly enhanced IgG1 and IgA antibody responses in wild-type mice compared with IFN-λ-free vaccines if administrated by the intranasal route. No such adjuvant effect of IFN-λ was observed if the vaccines were administrated by the subcutaneous or intraperitoneal routes. IFN-λ triggered the synthesis of thymic stromal lymphopoietin (TSLP) in epithelial cells of the upper airways which targeted migratory dendritic cells and boosted antigen-dependent germinal center reactions in draining lymph nodes and spleen. The IFN-λ/TSLP axis not only induced strongly increased responses to influenza subunit vaccines but also enhanced survival after lethal virus challenge. Thus, IFN-λ plays an important role in potentiating adaptive immune responses which initiate in the upper airways and it has great potential to increase the effectiveness of mucosal vaccines.

Choose secondary Session Vaccines and antivirals
Choose primary session Vaccines and antivirals

Primary author

Co-authors

Presentation materials

There are no materials yet.

Peer reviewing

Paper